Large-Scale Analysis of Drug Side Effects via Complex Regulatory Modules Composed of microRNAs, Transcription Factors and Gene Sets.

Identifying the occurrence mechanism of drug-induced side effects (SEs) is critical for design of drug target and new drug development. The expression of genes in biological processes is regulated by transcription factors(TFs) and/or microRNAs. Most of previous studies were focused on a single level of gene or gene sets, while studies about regulatory relationships of TFs, miRNAs and biological processes are very rare. Discovering the complex regulating relations among TFs, gene sets and miRNAs will be helpful for researchers to get a more comprehensive understanding about the mechanism of side reaction. In this study, a framework was proposed to construct the relationship network of gene sets, miRNAs and TFs involved in side effects. Through the construction of this network, the potential complex regulatory relationship in the occurrence process of the side effects was reproduced. The SE-gene set network was employed to characterize the significant regulatory SE-gene set interaction and molecular basis of accompanied side effects. A total of 117 side effects complex modules including four types of regulating patterns were obtained from the SE-gene sets-miRNA/TF complex regulatory network. In addition, two cases were used to validate the complex regulatory modules which could more comprehensively interpret occurrence mechanism of side effects.

A sensitive method for computing GO-based functional similarities among genes with 'shallow annotation'.

Methods for computing similarities among genes have attracted increasing attention for their applications in gene clustering, gene expression data analysis, protein interaction prediction and evaluation. To address the need for automatically computing functional similarities of genes, an important class of methods that computes functional similarities by comparing Gene Ontology (GO) annotations of genes has been developed. However, all of the currently available methods have some drawbacks; for example, they either ignore the specificity of the GO terms or do not consider the information contained within the GO structure. As a result, the existing methods perform weakly when the genes are annotated with 'shallow annotations'. Here, we propose a new method to compute functional similarities among genes based on their GO annotations and compare it with the widely-used G-SESAME method. The results show that the new method reliably distinguishes functional similarities among genes and demonstrate that the method is especially sensitive to genes with 'shallow annotations'. Moreover, our method has high correlations with sequence and EC similarities.

A sub-pathway-based approach for identifying drug response principal network.

MOTIVATION: The high redundancy of and high degree of cross-talk between biological pathways hint that a sub-pathway may respond more effectively or sensitively than the whole pathway. However, few current pathway enrichment analysis methods account for the sub-pathways or structures of the tested pathways. We present a sub-pathway-based enrichment approach for identifying a drug response principal network, which takes into consideration the quantitative structures of the pathways. RESULT: We validated this new approach on a microarray experiment that captures the transcriptional profile of dexamethasone (DEX)-treated human prostate cancer PC3 cells. Compared with GeneTrail and DAVID, our approach is more sensitive to the DEX response pathways. Specifically, not only pathways but also the principal components of sub-pathways and networks related to prostate cancer and DEX response could be identified and verified by literature retrieval.